Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Definitive Healthcare Corp.DH · Entity 1538 | Chief Legal Officer | October 01, 2026 | October 05, 2026 |
| RAPID MICRO BIOSYSTEMS, INC.RPID · Entity 6966 | SVP, GENERAL COUNSEL | March 09, 2023 | March 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Definitive Healthcare Corp.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 864,534 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 7,729 · Balance 864,534 F1: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of previously reported RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of previously reported RSUs.
RAPID MICRO BIOSYSTEMS, INC.
Report date March 09, 2023 · Filed March 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 128,698 |
Reported balance
After 2023-03-09 transaction · row 1
1 source rowRow 1 · 2023-03-09 · Grant · Acquired 86,700 · Balance 128,698 F1: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of March 9, 2023 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.24 · Expires 2033-03-08 | Direct | 196,700 |
Reported balance
After 2023-03-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-09 · Grant · Acquired 196,700 · Balance 196,700 F2: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on April 9, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of March 9, 2023 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
F2: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on April 9, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC | Definitive Healthcare Corp. DH · Entity 1538 | Tax withholdingClass A Common Stock | 7,729 | $0.94 | $7,235.12 |
DisclosureSEC source: 0001193125-26-414092 · ownership.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 864,534 F1 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of previously reported RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:05 UTC | Definitive Healthcare Corp. DH · Entity 1538 | Tax withholdingClass A Common Stock | 30,591 | $0.80 | $24,472.80 |
DisclosureSEC source: 0001193125-26-296167 · ownership.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 872,263 F1 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of previously reported RSUs. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:54 UTC | Definitive Healthcare Corp. DH · Entity 1538 | GrantClass A Common Stock | 481,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-077200 · ownership.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 902,854 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on March 1, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:30 UTC | Definitive Healthcare Corp. DH · Entity 1538 | GrantClass A Common Stock | 421,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019060 · form4-07022025_040712.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,349 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on July 1, 2026, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 196,700 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001866482-23-000003 · wf-form4_167875714297728.xml · derivative · entry 2 Paris Jonathan · CIK 0001866482 · SVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,700 Underlying: Class A Common Stock · 196,700 shares Expires 2033-03-08 F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on April 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 86,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001866482-23-000003 · wf-form4_167875714297728.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · SVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,698 F1 · shares: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of March 9, 2023 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 02:45 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | Tax withholdingClass A Common Stock | 5,054 | $1.30 | $6,570.20 |
DisclosureSEC source: 0001127602-23-005433 · form4.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,998 F1 · shares: Represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 3,302 shares acquired under the Rapid Micro Biosystems, Inc. employee stock purchase plan on September 14, 2022. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:39 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $7.82 | $0.00 |
DisclosureSEC source: 0001127602-22-005155 · form4.xml · derivative · entry 2 Paris Jonathan · CIK 0001866482 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Class A Common Stock · 87,500 shares Expires 2032-02-10 F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 11, 2022. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:39 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-005155 · form4.xml · nonDerivative · entry 1 Paris Jonathan · CIK 0001866482 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · shares: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 11, 2022 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.